Interleukin 6 and Interleukin 8 as Potential Biomarkers for Oral Cavity and Oropharyngeal Squamous Cell Carcinoma
Top Cited Papers
Open Access
- 1 August 2004
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 130 (8), 929-935
- https://doi.org/10.1001/archotol.130.8.929
Abstract
Head and neck squamous cell carcinoma is the sixth most common cancer in the world, and affects 50 000 Americans annually. Worldwide, cancers of the oral cavity and oropharynx represent a great public health problem. Squamous cell carcinoma of the oral cavity accounts for nearly 50% of all newly diagnosed cancers in India and is a leading cause of death in France.1Keywords
This publication has 13 references indexed in Scilit:
- Emerging molecular markers of cancerNature Reviews Cancer, 2002
- Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysisOncogene, 2001
- Estimates of the worldwide incidence of 25 major cancers in 1990International Journal of Cancer, 1999
- Squamous cell carcinoma of the head and neck: past progress and future promise.CA: A Cancer Journal for Clinicians, 1998
- Nucleic Acid-Based Methods for the Detection of CancerScience, 1997
- Serum levels of cytokines in patients with colorectal cancer: Possible involvement of interleukin-6 and interleukin-8 in hematogenous metastasisThe Esophagus, 1994
- Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma.The Journal of Experimental Medicine, 1994
- A method of comparing the areas under receiver operating characteristic curves derived from the same cases.Radiology, 1983
- A Comparison of Whole Mouth Resting and Stimulated Salivary Measurement ProceduresJournal of Dental Research, 1982
- The meaning and use of the area under a receiver operating characteristic (ROC) curve.Radiology, 1982